Person: SİVRİOĞLU, KONÇUY
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
SİVRİOĞLU
First Name
KONÇUY
Name
3 results
Search Results
Now showing 1 - 3 of 3
Publication Experimental investigation of the effect of thermal comfort parameters on cervical range of motion(Elsevier, 2015-11-01) Yiğit, Abdulvahap; Atmaca, İbrahim; Arslanoğlu, Nurullah; Sivrioğlu, Koncuy; YİĞİT, ABDULVAHAP; ARSLANOĞLU, NURULLAH; SİVRİOĞLU, KONÇUY; Uludağ Üniversitesi/Mühendislik Fakültesi/Makine Mühendisliği Bölümü; Uludağ Üniversitesi/Tıp Fakültesi/Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı; 0000-0003-4970-4490; 0000-0002-4296-9480; AAG-8211-2021; AAG-8193-2021; CIJ-7410-2022; FXK-0953-2022The most well-known ailment affecting the neck muscles is neck stiffness, caused by sharp changes in temperature, chilling of the muscles by air conditioning or drafts, and consequent painful muscle contractions. A stiff neck is typically characterized by soreness and difficulty in moving the neck especially when trying to turn the head to the side. A stiff neck may also be accompanied by a headache, neck pain, shoulder pain and/or arm pain. Reduced cervical range of motion (ROM) is a common finding in people with neck pain. Musculoskeletal disorders continue to represent a major source of pain and discomfort as well as a significant source of workday loss and workers' compensation costs.In this study, the effects of parameters in air conditioning such as temperature, humidity and air velocity on cervical ROM have been investigated experimentally. In this investigation, each of the three parameters was used as a variable while the others were kept constant in a controlled laboratory room, and the effects of the parameter variations were investigated. Based on the observation that individuals often enter the air conditioned room perspiring in summer conditions, both dry and sweaty conditions were examined. Finally, experimental data were assessed with ANOVA analyses, and cervical rotation was found to be influenced by temperature and air velocity, but not humidity. It was also determined that parameters (temperature, air velocity and humidity) are not effective factors on cervical motion limitation provided that indoor air conditions remain within comfort limits which are prescribed in current standards of ASHRAE Standard 55 - 2004 and ISO 7730.Publication Characteristics of patients with rheumatoid arthritis in Turkey: Results from the Turkish league against rheumatism rheumatoid arthritis registry(Turkish League Against Rheumatism, 2015-01-01) Bal, Ajda; Ataman, Şebnem; Bodur, Hatice; Rezvani, Aylin; Paker, Nurdan; Taştekin, Nurettin; Karatepe, Altınay Göksel; Borman, Pınar; Yener, Mahmut; Nas, Kemal; Sezgin, Melek; Yazgan, Pelin; Tekeoğlu, İbrahim; Doğu, Beril; Altay, Zühal; Kırnap, Mehmet; Gürğan, Alev; Gür, Ali; Hizmetli, Sami; Günendi, Zafer; Erdem, Rana; Uğurlu, Hatice; İnal, Elem; Ölmez, Neşe; Kozanoğlu, Erkan; Öken, Öznur; Özel, Sumru; Dündar, Ümit; Akıncı, Ayşen; Öztürk, Cihat; Sivrioğlu, Koncuy; Duruöz, Mehmet Tuncay; Aydoğ, Ece; Çapkın, Erhan; Altan, Lale; Evcik, Deniz; Durmuş, Oğuz; Yağcı, İlker; Şendur, Ömer Faruk; Sertpoyraz, Filiz Meryem; Özgül, Ahmet; Şenel, Kazım; Çapacı, Kazım; SİVRİOĞLU, KONÇUY; ALTAN İNCEOĞLU, LALE; Uludağ Üniversitesi/Tıp Fakültesi/Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı.; 0000-0002-4296-9480; AAG-8211-2021; AAH-1652-2021Objectives: This study investigates the demographic and clinical characteristics of patients with rheumatoid arthritis (RA) in Turkey, and attempts to identify strategies for the prevention, treatment, and support of RA.Patients and methods: A total of 2,359 patients (1,966 females, 393 males; mean age 51.6 +/- 12.5 years; range 18 to 75 years) with RA from 36 centers across Turkey, who were recorded in the Turkish League Against Rheumatism (TLAR) RA Registry between September 2007 and March 2011, were evaluated. Patients' demographic and clinical data were recorded. Disease activity, functional status, and radiographic damage were measured using the Disease Activity Score 28, the Health Assessment Questionnaire, and van der Heijde modified Sharp scoring method.Results: The mean duration of academic education received was 5.2 +/- 3.8 years, and 74.6% of the patients were homemakers. Non-biological disease-modifying anti-rheumatic drugs were used by 91.0% of the patients, while 10.2% used biological disease-modifying anti-rheumatic drugs. The mean Disease Activity Score 28, Health Assessment Questionnaire, and Sharp scores were 4.0 +/- 1.4, 0.38 +/- 0.37, and 31.2 +/- 57.1, respectively. Of the patients, 17.8% were in remission and 14.1% had low disease activity rates, while 42.7% and 25.5% had moderate and high disease activity rates.Conclusion: The majority of patients with RA in Turkey are middle-aged homemakers. Despite the high rates of disease-modifying anti-rheumatic drugs use, the majority of patients had moderate and high disease activity. These findings indicate that treatment needs of RA patients are not met sufficiently.Publication Botulinum toxin in poststroke spasticity(Marshfield Clinic, 2007-06-01) Özçakır, Şüheda; Sivrioğlu, Koncuy; ÖZÇAKIR, ŞÜHEDA; SİVRİOĞLU, KONÇUY; Uludağ Üniversitesi/Tıp Fakültesi/Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı; 0000-0002-4296-9480; AAH-5375-2021; AAG-8211-2021Poststroke hemiparesis, together with abnormal muscle tone, is a major cause of morbidity and disability. Although most hemiparetic patients are able to reach different ambulatory levels with rehabilitation efforts, upper and lower limb spasticity can impede activities of daily living, personal hygiene, ambulation and, in some cases, functional improvement. The goals of spasticity management include increasing mobility and range of motion, attaining better hygiene, improving splint wear and other functional activities. Conservative measures, such as positioning, stretching and exercise are essential in spasticity management, but alone often are inadequate to effectively control it. Oral antispastic medications often provide limited effects with short duration and frequent unwanted systemic side effects, such as weakness, sedation and dry mouth. Therefore, neuromuscular blockade by local injections have become the first choice for the treatment of focal spasticity, particularly in stroke patients. Botulinum toxin (BTX), being one of the most potent biological toxins, acts by blocking neuromuscular transmission via inhibiting acetylcholine release. Currently, focal spasticity is being treated successfully with BTX via injecting in the spastic muscles. Two antigenically distinct serotypes of BTX are available on the market as type A and B. Clinical studies of BTX used for spastic hemiplegic patients are reviewed in this article in two major categories, upper and lower limb applications. This review addresses efficacy in terms of outcome measures, such as muscle tone reduction and functional outcome, as well as safety issues. Application modifications of dose, dilutions, site of injections and combination therapies with BTX injections are also discussed.